Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 215, Issue 5, Pages 1301-1313
Publisher
Rockefeller University Press
Online
2018-04-27
DOI
10.1084/jem.20170584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
- (2017) Sinead O'Sullivan et al. NEUROPHARMACOLOGY
- Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
- (2017) Veit Rothhammer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway
- (2016) Katia Beider et al. CLINICAL CANCER RESEARCH
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
- (2015) N C Hait et al. Oncogenesis
- The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
- (2014) Kali Janes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- Sphingolipid metabolites in inflammatory disease
- (2014) Michael Maceyka et al. NATURE
- Spinal administration of mGluR5 antagonist prevents the onset of bortezomib induced neuropathic pain in rat
- (2014) Carla Ghelardini et al. NEUROPHARMACOLOGY
- Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat
- (2014) C.R. Robinson et al. NEUROSCIENCE
- Second generation S1P pathway modulators: Research strategies and clinical developments
- (2013) Marc Bigaud et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production
- (2013) Lei Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care
- (2013) J. S. de Moor et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Endogenous Interleukin-1β in Neuropathic Rats Enhances Glutamate Release from the Primary Afferents in the Spinal Dorsal Horn through Coupling with PresynapticN-Methyl-d-aspartic Acid Receptors
- (2013) Xisheng Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
- (2013) Paolo Neviani et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1 and TLR4 Signaling Are Involved in the Aggravated Murine Acute Graft-versus-Host Disease Caused by Delayed Bortezomib Administration
- (2013) Y. Liang et al. JOURNAL OF IMMUNOLOGY
- Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain
- (2013) Xisheng Yan et al. JOURNAL OF PHYSIOLOGY-LONDON
- Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase
- (2013) Kali Janes et al. PAIN
- Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse
- (2013) Valentina A. Carozzi et al. PLoS One
- Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
- (2013) Daniela Salvemini et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
- (2013) Yaqin Han et al. Frontiers in Pharmacology
- Neuropathic pain and cytokines: current perspectives
- (2013) Marzia Malcangio et al. Journal of Pain Research
- Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
- (2012) H. Zheng et al. EXPERIMENTAL NEUROLOGY
- An Oral Sphingosine 1-Phosphate Receptor 1 (S1P1) Antagonist Prodrug with Efficacy in Vivo: Discovery, Synthesis, and Evaluation
- (2012) Daniela Angst et al. JOURNAL OF MEDICINAL CHEMISTRY
- Supraspinal Peroxynitrite Modulates Pain Signaling by Suppressing the Endogenous Opioid Pathway
- (2012) J. W. Little et al. JOURNAL OF NEUROSCIENCE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death
- (2011) L. Alinari et al. BLOOD
- Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury
- (2011) SunJa Kim et al. BRAIN PATHOLOGY
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Chemotherapy-induced neuropathic pain
- (2011) Paul Farquhar-Smith Current Opinion in Supportive and Palliative Care
- Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation
- (2010) Ashley J. Snider et al. BIOCHIMIE
- 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
- (2010) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Sphingosine 1-Phosphate Receptor, S1PR1, Plays a Prominent But Not Exclusive Role in Enhancing the Excitability of Sensory Neurons
- (2010) Xian Xuan Chi et al. JOURNAL OF NEUROPHYSIOLOGY
- Counter-Regulation of Opioid Analgesia by Glial-Derived Bioactive Sphingolipids
- (2010) C. Muscoli et al. JOURNAL OF NEUROSCIENCE
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple reprobing of Western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide
- (2009) Alexis D. Sennepin et al. ANALYTICAL BIOCHEMISTRY
- Glutamate Transporters Prevent Excessive Activation of NMDA Receptors and Extrasynaptic Glutamate Spillover in the Spinal Dorsal Horn
- (2009) Hui Nie et al. JOURNAL OF NEUROPHYSIOLOGY
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
- (2009) N. C. Hait et al. SCIENCE
- Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1 , Interleukin-6, and Tumor Necrosis Factor- in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord
- (2008) Y. Kawasaki et al. JOURNAL OF NEUROSCIENCE
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now